# A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

> **NCT00001122** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 74 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nelfinavir mesylate
- **DRUG:** Efavirenz
- **DRUG:** Stavudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00001122
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2003-10
- **Final completion:** —
- **Target enrollment:** 74 (—)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001122, "A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00001122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*